Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
China · Delayed Price · Currency is CNY 26.34
+4.39 (20.00%)
Jul 10, 2026, 3:05 PM CST
SHE:300255 Market Cap
SHE:300255 has a market cap or net worth of 24.21 billion as of July 10, 2026. Its market cap has decreased by -48.10% in one year.
Market Cap
24.21B
Enterprise Value
26.32B
Revenue
872.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.34
Market Cap Chart
Since August 19, 2011, SHE:300255's market cap has increased from 3.35B to 24.21B, an increase of 622.90%. That is a compound annual growth rate of 14.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 24.21B | -57.58% |
| Dec 31, 2025 | 57.07B | 210.66% |
| Dec 31, 2024 | 18.37B | 53.65% |
| Dec 29, 2023 | 11.96B | 137.41% |
| Dec 30, 2022 | 5.04B | -32.60% |
| Dec 31, 2021 | 7.47B | 31.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Suzhou Zelgen Biopharmaceuticals | 38.38B |
| Beijing Wantai Biological Pharmacy Enterprise | 35.21B |
| Shanghai RAAS Blood Products | 30.19B |
| Chongqing Zhifei Biological Products | 29.13B |
| Beijing Tiantan Biological Products | 23.89B |
| Hualan Biological Engineering | 23.39B |
| Xiamen Amoytop Biotech | 22.74B |
| Yili Chuanning Biotechnology | 18.78B |